Metabolites related to gut bacterial metabolism, peroxisome proliferator-activated receptor-alpha activation, and insulin sensitivity are associated with physical function in functionally-limited older adults

Aging Cell

Volumn 13, Issue 5, 2014, Pages 918-925

  Lustgarten, Michael S ^a   Price, Lori L ^b   Chalé, Angela ^a   Fielding, Roger A ^a  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Aging; Gut bacterial metabolites; Insulin sensitivity; Metabolomics; Peroxisome proliferator activated receptor alpha; Physical function

Indexed keywords

ACYLCARNITINE; AMINO ACID; CINNAMOYLGLYCINE; DIMETHYLGLYCINE; FATTY ACID; HYDROCINNAMIC ACID; INDICAN; INSULIN; N METHYLPROLINE; P CRESOL SULFATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHENOL SULFATE; SEROTONIN; TRANS UROCANATE; UNCLASSIFIED DRUG; VALERIC ACID;

AGED; ARTICLE; BACTERIAL METABOLISM; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY FIBER; FEMALE; HUMAN; INSULIN SENSITIVITY; INTESTINE FLORA; LEAN BODY WEIGHT; MALE; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN INTAKE; RESISTANCE TRAINING; WALKING DIFFICULTY; WHEY; AGE; BACTERIUM; GASTROINTESTINAL TRACT; INSULIN RESISTANCE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); VERY ELDERLY;

BACTERIA (MICROORGANISMS);

AGE FACTORS; AGED; AGED, 80 AND OVER; BACTERIA; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INSULIN RESISTANCE; MALE; PPAR ALPHA; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84925257367     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.12251     Document Type: Article

References (58)

1. Barker HA (1981) Amino acid degradation by anaerobic bacteria. Annu. Rev. Biochem. 50, 23-40.
2. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. R. Stat. Soc. Series B Stat. Methodol. 57, 289-300.
3. Boelaert J, t'Kindt R, Schepers E, Jorge L, Glorieux G, Neirynck N, Lynen F, Sandra P, Vanholder R, Sandra K (2013) State-of-the-art non-targeted metabolomics in the study of chronic kidney disease. Metabolomics 10, 425-442.
4. Brooks JB, Nunez-Montiel OL, Wycoff BJ, Moss CW (1984) Frequency-pulsed electron capture gas-liquid chromatographic analysis of metabolites produced by Clostridium difficile in broth enriched with amino acids. J. Clin. Microbiol. 20, 539-548.
5. Burke LM, Winter JA, Cameron-Smith D, Enslen M, Farnfield M, Decombaz J (2012) Effect of intake of different dietary protein sources on plasma amino Acid profiles at rest and after exercise. Int J Sport Nutr Exerc. Metab. 22, 452-462.
6. Bursac Z, Gauss CH, Williams DK, Hosmer DW (2008) Purposeful selection of variables in logistic regression. Source Code Biol. Med. 3, 17.
7. Caldwell J, Moffatt JR, Smith RL (1976) Post-mortem survival of hippuric acid formation in rat and human cadaver tissue samples. Xenobiotica 6, 275-280.
8. Chale A, Cloutier GJ, Hau C, Phillips EM, Dallal GE, Fielding RA (2012) Efficacy of whey protein supplementation on resistance exercise-induced changes in lean mass, muscle strength, and physical function in mobility-limited older adults. J. Gerontol. A Biol. Sci. Med. Sci. 68, 682-690.
9. Choi JJ, Eum SY, Rampersaud E, Daunert S, Abreu MT, Toborek M (2013) Exercise attenuates PCB-induced changes in the mouse gut microbiome. Environ. Health Perspect. 121, 725-730.
10. Coen PM, Jubrias SA, Distefano G, Amati F, Mackey DC, Glynn NW, Manini TM, Wohlgemuth SE, Leeuwenburgh C, Cummings SR, Newman AB, Ferrucci L, Toledo FG, Shankland E, Conley KE, Goodpaster BH (2013) Skeletal muscle mitochondrial energetics are associated with maximal aerobic capacity and walking speed in older adults. J. Gerontol. A Biol. Sci. Med. Sci. 68, 447-455.
11. Cummings JH (1983) Fermentation in the human large intestine: evidence and implications for health. Lancet 1, 1206-1209.
12. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E (2009) Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal. Chem. 81, 6656-6667.
13. Fiehn O (2002) Metabolomics - the link between genotypes and phenotypes. Plant Mol. Biol. 48, 155-171.
14. Gillingham LG, Harris-Janz S, Jones PJ (2011) Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids 46, 209-228.
15. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB (1994) A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J. Gerontol. 49, M85-94.
16. Harris T, Kovar MG, Suzman R, Kleinman JC, Feldman JJ (1989) Longitudinal study of physical ability in the oldest-old. Am. J. Public Health 79, 698-702.
17. Heffernan KS, Manini TM, Hsu FC, Blair SN, Nicklas BJ, Kritchevsky SB, Newman AB, Sutton-Tyrrell K, Church TS, Haskell WL, Fielding RA (2012) Relation of pulse pressure to long-distance gait speed in community-dwelling older adults: findings from the LIFE-P study. PLoS One 7, e49544.
18. Huffman KM, Shah SH, Stevens RD, Bain JR, Muehlbauer M, Slentz CA, Tanner CJ, Kuchibhatla M, Houmard JA, Newgard CB, Kraus WE (2009) Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 32, 1678-1683.
19. Hwang JH, Kim DW, Jo EJ, Kim YK, Jo YS, Park JH, Yoo SK, Park MK, Kwak TH, Kho YL, Han J, Choi HS, Lee SH, Kim JM, Lee I, Kyung T, Jang C, Chung J, Kweon GR, Shong M (2009) Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice. Diabetes 58, 965-974.
20. Issemann I, Green S (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645-650.
21. Jette AM (2006) Toward a common language for function, disability, and health. Phys. Ther. 86, 726-734.
22. Kalhan SC, Guo L, Edmison J, Dasarathy S, McCullough AJ, Hanson RW, Milburn M (2011) Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism 60, 404-413.
23. Launer LJ, Harris T, Rumpel C, Madans J (1994) Body mass index, weight change, and risk of mobility disability in middle-aged and older women. The epidemiologic follow-up study of NHANES I. JAMA 271, 1093-1098.
24. Lee J, Wolfgang MJ (2012) Metabolomic profiling reveals a role for CPT1c in neuronal oxidative metabolism. BMC Biochem. 13, 23.
25. Levey AS (1990) Measurement of renal function in chronic renal disease. Kidney Int. 38, 167-184.
26. Lewis RC, Meeker JD, Peterson KE, Lee JM, Pace GG, Cantoral A, Tellez-Rojo MM (2013) Predictors of urinary bisphenol A and phthalate metabolite concentrations in Mexican children. Chemosphere 93, 2390-2398.
27. Lum H, Sloane R, Huffman KM, Kraus VB, Thompson DK, Kraus WE, Bain JR, Stevens R, Pieper CF, Taylor GA, Newgard CB, Cohen HJ, Morey MC (2011) Plasma acylcarnitines are associated with physical performance in elderly men. J. Gerontol. A Biol. Sci. Med. Sci. 66, 548-553.
28. Mainil J (2006) Genus Clostridium: Clostridia in Medical, Veterinary and Food Microbiology : Diagnosis and Typing. Luxembourg: European Concerted Action Project, European Commission. Directorate General for Research, pp. 136.
29. Makowski L, Noland RC, Koves TR, Xing W, Ilkayeva OR, Muehlbauer MJ, Stevens RD, Muoio DM (2009) Metabolic profiling of PPARalpha-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. FASEB J. 23, 586-604.
30. Manna SK, Patterson AD, Yang Q, Krausz KW, Li H, Idle JR, Fornace AJ Jr, Gonzalez FJ (2010) Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse. J. Proteome Res. 9, 4176-4188.
31. Matsumoto M, Kibe R, Ooga T, Aiba Y, Kurihara S, Sawaki E, Koga Y, Benno Y (2012) Impact of intestinal microbiota on intestinal luminal metabolome. Sci. Rep. 2, 233.
32. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
33. McCormack SE, Shaham O, McCarthy MA, Deik AA, Wang TJ, Gerszten RE, Clish CB, Mootha VK, Grinspoon SK, Fleischman A (2013) Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr. Obes. 8, 52-61.
34. McFarland LV, Surawicz CM, Stamm WE (1990) Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J. Infect. Dis. 162, 678-684.
35. Meister A (1973) On the enzymology of amino acid transport. Science 180, 33-39.
36. Meyers KJ, Chu J, Mosley TH, Kardia SL (2010) SNP-SNP interactions dominate the genetic architecture of candidate genes associated with left ventricular mass in African-Americans of the GENOA study. BMC Med. Genet. 11, 160.
37. Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W (2006) International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol. Rev. 58, 726-741.
38. Mickey RM, Greenland S (1989) The impact of confounder selection criteria on effect estimation. Am. J. Epidemiol. 129, 125-137.
39. Muoio DM, MacLean PS, Lang DB, Li S, Houmard JA, Way JM, Winegar DA, Corton JC, Dohm GL, Kraus WE (2002) Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J. Biol. Chem. 277, 26089-26097.
40. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR, Yancy WS Jr, Eisenson H, Musante G, Surwit RS, Millington DS, Butler MD, Svetkey LP (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9, 311-326.
41. Newman AB, Simonsick EM, Naydeck BL, Boudreau RM, Kritchevsky SB, Nevitt MC, Pahor M, Satterfield S, Brach JS, Studenski SA, Harris TB (2006) Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA 295, 2018-2026.
42. Nguyen D, Samson SL, Reddy VT, Gonzalez EV, Sekhar RV (2013) Impaired mitochondrial fatty acid oxidation and insulin resistance in aging: novel protective role of glutathione. Aging Cell 12, 415-425.
43. Niwa T (2011) Update of uremic toxin research by mass spectrometry. Mass Spectrom. Rev. 30, 510-521.
44. Ohta T, Masutomi N, Tsutsui N, Sakairi T, Mitchell M, Milburn MV, Ryals JA, Beebe KD, Guo L (2009) Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicol. Pathol. 37, 521-535.
45. Patterson AD, Slanar O, Krausz KW, Li F, Hofer CC, Perlik F, Gonzalez FJ, Idle JR (2009) Human urinary metabolomic profile of PPARalpha induced fatty acid beta-oxidation. J. Proteome Res. 8, 4293-4300.
46. Poynter ME, Daynes RA (1998) Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J. Biol. Chem. 273, 32833-32841.
47. Puthoff ML, Nielsen DH (2007) Relationships among impairments in lower-extremity strength and power, functional limitations, and disability in older adults. Phys. Ther. 87, 1334-1347.
48. Rakhshandehroo M, Sanderson LM, Matilainen M, Stienstra R, Carlberg C, de Groot PJ, Muller M, Kersten S (2007) Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling. PPAR Res. 2007, 26839.
49. Ruiz JR, Sui X, Lobelo F, Morrow JR Jr, Jackson AW, Sjostrom M, Blair SN (2008) Association between muscular strength and mortality in men: prospective cohort study. BMJ 337, a439.
50. Schachter D, Taggart JV (1954) Glycine N-acylase: purification and properties. J. Biol. Chem. 208, 263-275.
51. Segerstrom AB, Elgzyri T, Eriksson KF, Groop L, Thorsson O, Wollmer P (2011) Exercise capacity in relation to body fat distribution and muscle fibre distribution in elderly male subjects with impaired glucose tolerance, type 2 diabetes and matched controls. Diabetes Res. Clin. Pract. 94, 57-63.
52. Stefan N, Kantartzis K, Celebi N, Staiger H, Machann J, Schick F, Cegan A, Elcnerova M, Schleicher E, Fritsche A, Haring HU (2010) Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans. Diabetes Care 33, 405-407.
53. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA 100, 9440-9445.
54. Sung B, Park S, Yu BP, Chung HY (2004) Modulation of PPAR in aging, inflammation, and calorie restriction. J. Gerontol. A Biol. Sci. Med. Sci. 59, 997-1006.
55. Takeda S, Harada M, Su S, Okajima S, Miyoshi H, Yoshida K, Nishimura H, Okamoto Y, Amamoto T, Watanabe K, Omiecinski CJ, Aramaki H (2013) Induction of the fatty acid 2-hydroxylase (FA2H) gene by Delta(9)-tetrahydrocannabinol in human breast cancer cells. J. Toxicol. Sci. 38, 305-308.
56. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G (2009) Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl Acad. Sci. USA 106, 3698-3703.
57. Wurtz P, Soininen P, Kangas AJ, Ronnemaa T, Lehtimaki T, Kahonen M, Viikari JS, Raitakari OT, Ala-Korpela M (2013) Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care 36, 648-655.
58. Zhen Y, Krausz KW, Chen C, Idle JR, Gonzalez FJ (2007) Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation. Mol. Endocrinol. 21, 2136-2151.